{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:33:10Z","timestamp":1767713590799},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Heart and Stroke Foundation of Alberta"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10554-018-1410-5","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T11:53:21Z","timestamp":1531742001000},"page":"1937-1946","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping"],"prefix":"10.1007","volume":"34","author":[{"given":"Na\u2019ama","family":"Avitzur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Satriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Narous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reis","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Dobko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Flewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen P.","family":"Lydell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nowell M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"publisher","first-page":"129138","DOI":"10.1016\/j.pharmthera.2017.06.011","volume":"180","author":"KM Alexander","year":"2017","unstructured":"Alexander KM, Singh A, Falk RH (2017) Novel pharmacotherapies for cardiac amyloidosis. Pharmacol Ther 180: 129\u2013138. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2017.06.011","journal-title":"Pharmacol Ther"},{"issue":"10","key":"1410_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1200\/JCO.2015.63.6530","volume":"34","author":"MA Gertz","year":"2016","unstructured":"Gertz MA, Landau H, Comenzo RL, Seldin D, Weiss B, Zonder J, Merlini G, Schonland S, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie SD, Liedtke M (2016) First-in-human phase I\/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction. J Clin Oncol 34(10):1097\u20131103. \n                    https:\/\/doi.org\/10.1200\/JCO.2015.63.6530","journal-title":"J Clin Oncol"},{"issue":"1","key":"1410_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11897-013-0182-4","volume":"11","author":"M Hanna","year":"2014","unstructured":"Hanna M (2014) Novel drugs targeting transthyretin amyloidosis. Curr Heart Fail Rep 11(1):50\u201357. \n                    https:\/\/doi.org\/10.1007\/s11897-013-0182-4","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"1410_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","volume":"18","author":"A Castano","year":"2012","unstructured":"Castano A, Helmke S, Alvarez J, Delisle S, Maurer MS (2012) Diflunisal for ATTR cardiac amyloidosis. Congest Heart Fail 18(6):315\u2013319. \n                    https:\/\/doi.org\/10.1111\/j.1751-7133.2012.00303.x","journal-title":"Congest Heart Fail"},{"issue":"2","key":"1410_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/13506129.2014.997872","volume":"22","author":"Y Sekijima","year":"2015","unstructured":"Sekijima Y, Tojo K, Morita H, Koyama J, Ikeda S (2015) Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. Amyloid 22(2):79\u201383. \n                    https:\/\/doi.org\/10.3109\/13506129.2014.997872","journal-title":"Amyloid"},{"issue":"2","key":"1410_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/13506129.2016.1148025","volume":"23","author":"JN Higaki","year":"2016","unstructured":"Higaki JN, Chakrabartty A, Galant NJ, Hadley KC, Hammerson B, Nijjar T, Torres R, Tapia JR, Salmans J, Barbour R, Tam SJ, Flanagan K, Zago W, Kinney GG (2016) Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin. Amyloid 23(2):86\u201397. \n                    https:\/\/doi.org\/10.3109\/13506129.2016.1148025","journal-title":"Amyloid"},{"key":"1410_CR7","doi-asserted-by":"publisher","unstructured":"Castano A, Manson DK, Maurer MS, Bokhari S (2017) Transthyretin cardiac amyloidosis in older adults: optimizing cardiac imaging to the corresponding diagnostic and management goal. Curr Cardiovasc Risk Rep 11(\n                    https:\/\/doi.org\/10.1007\/s12170-017-0541-x","DOI":"10.1007\/s12170-017-0541-x"},{"issue":"11","key":"1410_CR8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley A-M, Page J, Hall ML, Burniston M, Gopaul D, Lane T, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD (2014) Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J 15(11):1289\u20131298. \n                    https:\/\/doi.org\/10.1093\/ehjci\/jeu107","journal-title":"Eur Heart J"},{"issue":"4","key":"1410_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/eurheartj\/ehu442","volume":"36","author":"TD Karamitsos","year":"2015","unstructured":"Karamitsos TD, Neubauer S (2015) T1 mapping and amyloid cardiomyopathy: how much better can it get? Eur Heart J 36(4):203\u2013205. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu442","journal-title":"Eur Heart J"},{"issue":"4","key":"1410_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","volume":"103","author":"FL Ruberg","year":"2009","unstructured":"Ruberg FL, Appelbaum E, Davidoff R, Ozonoff A, Kissinger KV, Harrigan C, Skinner M, Manning WJ (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103(4):544\u2013549. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2008.09.105","journal-title":"Am J Cardiol"},{"issue":"5","key":"1410_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13244-015-0420-2","volume":"6","author":"AZ Khawaja","year":"2015","unstructured":"Khawaja AZ, Cassidy DB, Al Shakarchi J, McGrogan DG, Inston NG, Jones RG (2015) Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines. Insights Imaging 6(5):553\u2013558","journal-title":"Insights Imaging"},{"issue":"1","key":"1410_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","volume":"19","author":"LK Williams","year":"2017","unstructured":"Williams LK, Forero JF, Popovic ZB, Phelan D, Delgado D, Rakowski H, Wintersperger BJ, Thavendiranathan P (2017) Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. J Cardiovasc Magn Reson 19(1):61. \n                    https:\/\/doi.org\/10.1186\/s12968-017-0376-0","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"1410_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijcard.2011.10.137","volume":"166","author":"A Schuster","year":"2013","unstructured":"Schuster A, Paul M, Bettencourt N, Morton G, Chiribiri A, Ishida M, Hussain S, Jogiya R, Kutty S, Bigalke B, Perera D, Nagel E (2013) Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy. Int J Cardiol 166(2):413\u2013420","journal-title":"Int J Cardiol"},{"issue":"1","key":"1410_CR14","doi-asserted-by":"publisher","first-page":"12259","DOI":"10.1038\/s41598-017-12539-5","volume":"7","author":"P Piras","year":"2017","unstructured":"Piras P, Teresi L, Puddu PE, Torromeo C, Young AA, Suinesiaputra A, Medrano-Gracia P (2017) Morphologically normalized left ventricular motion indicators from MRI feature tracking characterize myocardial infarction. Sci Rep 7(1):12259","journal-title":"Sci Rep"},{"issue":"12","key":"1410_CR15","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1111\/echo.13355","volume":"33","author":"Q Lo","year":"2016","unstructured":"Lo Q, Haluska B, Chia EM, Lin MW, Richards D, Marwick T, Thomas L (2016) Alterations in regional myocardial deformation assessed by strain imaging in cardiac amyloidosis. Echocardiography 33(12):1844\u20131853. \n                    https:\/\/doi.org\/10.1111\/echo.13355","journal-title":"Echocardiography"},{"issue":"4","key":"1410_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6(4):488\u2013497. \n                    https:\/\/doi.org\/10.1016\/j.jcmg.2012.11.013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"1410_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","volume":"7","author":"JA White","year":"2014","unstructured":"White JA, Kim HW, Shah D, Fine N, Kim KY, Wendell DC, Al-Jaroudi W, Parker M, Patel M, Gwadry-Sridhar F, Judd RM, Kim RJ (2014) CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging 7(2):143\u2013156. \n                    https:\/\/doi.org\/10.1016\/j.jcmg.2013.09.019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1410_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","volume":"21","author":"S Bokhari","year":"2014","unstructured":"Bokhari S, Shahzad R, Castano A, Maurer MS (2014) Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol 21(1):175\u2013184. \n                    https:\/\/doi.org\/10.1007\/s12350-013-9803-2","journal-title":"J Nucl Cardiol"},{"key":"1410_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1532-429X-12-69","volume":"12:","author":"SKFV Piechnik","year":"2010","unstructured":"Piechnik SKFV, Dall\u2019Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD (2010) Shortened modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12: 69","journal-title":"J Cardiovasc Magn Reson"},{"key":"1410_CR20","doi-asserted-by":"publisher","unstructured":"Suinesiaputra A, Bluemke DA, Cowan BR, Friedrich MG, Kramer CM, Kwong R, Plein S, Schulz-Menger J, Westenberg JJ, Young AA, Nagel E (2015) Quantification of LV function and mass by cardiovascular magnetic resonance: multi-center variability and consensus contours. J Cardiovasc Magn Reson. \n                    https:\/\/doi.org\/10.1186\/s12968-015-0170-9","DOI":"10.1186\/s12968-015-0170-9"},{"key":"1410_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1532-429X-15-35","volume":"15","author":"J Schulz-Menger","year":"2013","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, Kim RJ, von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, Plein S, Nagel E (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"1410_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jmri.23875","volume":"38","author":"M Salerno","year":"2013","unstructured":"Salerno M, Janardhanan R, Jiji RS, Brooks J, Adenaw N, Mehta B, Yang Y, Antkowiak P, Kramer CM, Epstein FH (2013) Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging 38(1):217\u2013224. \n                    https:\/\/doi.org\/10.1002\/jmri.23875","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"1410_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/mrm.1910230205","volume":"23","author":"LD Diesbourg","year":"1992","unstructured":"Diesbourg LD, Prato FS, Wisenberg G, Drost DJ, Marshall TP, Carroll SE, O\u2019Neill B (1992) Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 23(2):239\u2013253","journal-title":"Magn Reson Med"},{"issue":"12","key":"1410_CR24","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s10554-017-1199-7","volume":"33","author":"A Satriano","year":"2017","unstructured":"Satriano A, Heydari B, Narous M, Exner DV, Mikami Y, Attwood MM, Tyberg JV, Lydell CP, Howarth AG, Fine NM, White JA (2017) Clinical feasibility and validation of 3D principal strain analysis from cine MRI: comparison to 2D strain by MRI and 3D speckle tracking echocardiography. Int J Cardiovasc Imaging 33(12):1979\u20131992","journal-title":"Int J Cardiovasc Imaging"},{"key":"1410_CR25","first-page":"287294","volume":"2010","author":"A Cohen","year":"2010","unstructured":"Cohen A, Comenzo RL (2010) Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematol Am Soc Hematol Educ Progr 2010: 287\u2013294","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"11","key":"1410_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11886-015-0653-1","volume":"17","author":"MN Vranian","year":"2015","unstructured":"Vranian MN, Sperry BW, Valent J, Hanna M (2015) Emerging advances in the management of cardiac amyloidosis. Curr Cardiol Rep 17(11):100. \n                    https:\/\/doi.org\/10.1007\/s11886-015-0653-1","journal-title":"Curr Cardiol Rep"},{"issue":"9","key":"1410_CR27","doi-asserted-by":"publisher","first-page":"1166e11166e10","DOI":"10.1016\/j.cjca.2016.05.008","volume":"32","author":"DL Narotsky","year":"2016","unstructured":"Narotsky DL, Castano A, Weinsaft JW, Bokhari S, Maurer MS (2016) Wild-type transthyretin cardiac amyloidosis: novel insights from advanced imaging. Can J Cardiol 32(9):1166e1\u20131166e10. \n                    https:\/\/doi.org\/10.1016\/j.cjca.2016.05.008","journal-title":"Can J Cardiol"},{"issue":"2","key":"1410_CR28","doi-asserted-by":"publisher","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","volume":"1","author":"SM Banypersad","year":"2012","unstructured":"Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD (2012) Updates in cardiac amyloidosis: a review. J Am Heart Assoc 1(2):e000364. \n                    https:\/\/doi.org\/10.1161\/JAHA.111.000364","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1410_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19(1):75","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"1410_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","volume":"36","author":"SM Banypersad","year":"2015","unstructured":"Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, Piechnik SK, Whelan CJ, Herrey AS, Gillmore JD, Lachmann HJ, Wechalekar AD, Hawkins PN, Moon JC (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36(4):244\u2013251. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu444","journal-title":"Eur Heart J"},{"issue":"14","key":"1410_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","volume":"135","author":"MS Maurer","year":"2017","unstructured":"Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C (2017) Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 135(14):1357\u20131377. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024438","journal-title":"Circulation"},{"issue":"3","key":"1410_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/hrt.2005.061911","volume":"92","author":"E Perugini","year":"2006","unstructured":"Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L, Salvi F, Lovato L, Branzi A, Fattori R (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92(3):343\u2013349. \n                    https:\/\/doi.org\/10.1136\/hrt.2005.061911","journal-title":"Heart"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-018-1410-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-018-1410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-018-1410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:08:11Z","timestamp":1563217691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-018-1410-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1007\/s10554-018-1410-5","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"12 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ms. Na\u2019ama Avitzur declares that she has no conflict of interest. Dr. Alessandro Satriano declares that he has no conflict of interest. Dr. Muhammad Sarim Afzal declares that he has no conflict of interest. Ms. Mariam Narous declares that she has no conflict of interest. Dr. Yoko Mikami declares that she has no conflict of interest. Mr. Reis Hansen declares that he has no conflict of interest. Mr. Gary Dobko declares that he has no conflict of interest. Mrs. Jacqueline Flewitt declares that she has no conflict of interest. Dr. Carmen P. Lydell declares that she has no conflict of interest. Dr. Andrew G. Howarth receives consulting fees from Amgen. Dr. Kelvin Chow is employed by Siemens Medical Solutions USA. Inc. Dr. Nowell M. Fine receives consulting fees from Novartis and Pfizer. Dr. James A. White received salary support from the Heart and Stroke Foundation of Alberta during this study, receives research grants from Circle Cardiovascular Inc., and is a shareholder of Cohesic Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}